Fundraising Fox
/Companies
Sign in

George Medicines

3 known investors

Find your way into George Medicines

Sign up to see every warm intro you have to George Medicines

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the George Medicines team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

George Medicines develops single-pill combination therapies for cardiometabolic diseases such as hypertension and diabetes, leveraging research from The George Institute for Global Health. The company targets patients with low medication adherence and aims to reduce the burden of non-communicable diseases on patients, families, and health systems.

BiotechDigital HealthHealthtechMedical Devices

Founders & leadership

MMMark Mallon
Mark MallonChief Executive OfficerHe brings 25+ years of experience in life sciences leadership, with a track record of organizational transformation and product launches across US and international markets.
PAProfessor Anthony Rodgers
Professor Anthony RodgersChief Medical Officer
DKDr Karl Roberts
Dr Karl RobertsChief Operating OfficerDr. Karl Roberts is Chief Operating Officer of George Medicines and brings extensive senior management experience across pharmaceutical operations, strategic planning, and commercial development in UK and international markets.

Investors · 3

Brandon Capital✓ confirmed by George MedicinesMelbourne

How we know: the company's own site · Not right? Tell us

Brandon Capital PartnersreportedMelbourne

How we know: funding news · Not right? Tell us

In the news

George Medicines extends global commercialization of GMRx2 into Australia and New Zealand with Arrotex licensing agreement - BioSpacebiospace.com · Mar 2026Potential of George Medicines’ novel, low-dose, triple combination pill to transform management of hypertension highlighted at global congressfinance.yahoo.com · Sep 2024

Frequently asked questions

What does George Medicines do?
George Medicines develops single-pill combination therapies for cardiometabolic diseases such as hypertension and diabetes, leveraging research from The George Institute for Global Health. The company targets patients with low medication adherence and aims to reduce the burden of non-communicable diseases on patients, families, and health systems.
Who are George Medicines's investors?
George Medicines's investors include Brandon BioCatalyst, Brandon Capital, Brandon Capital Partners.